BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 28601860)

  • 1. Characteristics and Long-Term Outcome of Neurosarcoidosis: A Population-Based Study from 1976-2013.
    Ungprasert P; Crowson CS; Matteson EL
    Neuroepidemiology; 2017; 48(3-4):87-94. PubMed ID: 28601860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurosarcoidosis.
    Ungprasert P; Matteson EL
    Rheum Dis Clin North Am; 2017 Nov; 43(4):593-606. PubMed ID: 29061245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated neurosarcoidosis: case series in 2 sarcoidosis centers.
    Nozaki K; Scott TF; Sohn M; Judson MA
    Neurologist; 2012 Nov; 18(6):373-7. PubMed ID: 23114669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurosarcoidosis: clinical presentations and changing treatment patterns in an Irish Caucasian population.
    O'Connell K; Williams L; Jones J; McCabe DJH; Murphy D; Killeen R; Tubridy N; O'Riordan S; McGuigan C
    Ir J Med Sci; 2017 Aug; 186(3):759-766. PubMed ID: 28101825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurosarcoidosis: Diagnosis and therapeutic issues].
    Cohen Aubart F; Galanaud D; Haroche J; Psimaras D; Mathian A; Hié M; Le-Thi Huong Boutin D; Charlotte F; Maillart E; Maisonobe T; Amoura Z
    Rev Med Interne; 2017 Jun; 38(6):393-401. PubMed ID: 27884456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single Center Experience with Isolated Spinal Cord Neurosarcoidosis.
    Park BJ; Ray E; Bathla G; Bruch LA; Streit JA; Cho TA; Hitchon PW
    World Neurosurg; 2021 Dec; 156():e398-e407. PubMed ID: 34583004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurosarcoidosis: clinical characteristics, diagnosis, and treatment in eight Chinese patients.
    Wang F; Guo D; Liu Z; Zhou A; Wei C; Jia J
    Neurol Sci; 2018 Oct; 39(10):1725-1733. PubMed ID: 30088165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurosarcoidosis: a personal perspective based on the study of 37 patients.
    Sharma OP
    Chest; 1997 Jul; 112(1):220-8. PubMed ID: 9228380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcoidosis of the central nervous system: Safety and efficacy of treatment, and experience of biological therapies.
    Kidd DP
    Clin Neurol Neurosurg; 2020 Jul; 194():105811. PubMed ID: 32330798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurosarcoidosis according to Zajicek and Scolding criteria: 15 probable and definite cases, their treatment and outcomes.
    Cação G; Branco A; Meireles M; Alves JE; Mateus A; Silva AM; Santos E
    J Neurol Sci; 2017 Aug; 379():84-88. PubMed ID: 28716286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurosarcoidosis: an update on diagnosis and therapy.
    Ungprasert P; Sukpornchairak P; Moss BP; Ribeiro Neto ML; Culver DA
    Expert Rev Neurother; 2022 Aug; 22(8):695-705. PubMed ID: 35914766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurosarcoidosis associated with intracerebral haemorrhage: a challenge in diagnosis and management.
    Maskery MP; Cooper PN; Pace A
    Pract Neurol; 2018 Jun; 18(3):246-249. PubMed ID: 29363557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging findings in spinal sarcoidosis: a report of 18 cases and review of the current literature.
    Soni N; Bathla G; Pillenahalli Maheshwarappa R
    Neuroradiol J; 2019 Feb; 32(1):17-28. PubMed ID: 30311851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurosarcoidosis in a Tertiary Referral Center: A Cross-Sectional Cohort Study.
    Leonhard SE; Fritz D; Eftimov F; van der Kooi AJ; van de Beek D; Brouwer MC
    Medicine (Baltimore); 2016 Apr; 95(14):e3277. PubMed ID: 27057889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal ultra-extensive transverse myelitis as a manifestation of neurosarcoidosis.
    Wang L; Li Y
    J Neurol Sci; 2015 Aug; 355(1-2):64-7. PubMed ID: 26027786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cerebrospinal fluid CD4/CD8 ratio and interleukin-6 and -10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative study.
    Chazal T; Costopoulos M; Maillart E; Fleury C; Psimaras D; Legendre P; Pineton de Chambrun M; Haroche J; Lubetzki C; Amoura Z; Legarff-Tavernier M; Cohen Aubart F
    Eur J Neurol; 2019 Oct; 26(10):1274-1280. PubMed ID: 31021023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cranial base manifestations of neurosarcoidosis: a review of 305 patients.
    Carlson ML; White JR; Espahbodi M; Haynes DS; Driscoll CL; Aksamit AJ; Pawate S; Lane JI; Link MJ
    Otol Neurotol; 2015 Jan; 36(1):156-66. PubMed ID: 25029595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis.
    Fritz D; van de Beek D; Brouwer MC
    BMC Neurol; 2016 Nov; 16(1):220. PubMed ID: 27846819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurosarcoidosis: Longitudinal experience in a single-center, academic healthcare system.
    Lord J; Paz Soldan MM; Galli J; Salzman KL; Kresser J; Bacharach R; DeWitt LD; Klein J; Rose J; Greenlee J; Clardy SL
    Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32404428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical features and treatment of sarcoidosis involving the central nervous system].
    Akimoto J; Yamanaka S; Takeda Y; Ito H; Masuda M; Utsumi H
    No To Shinkei; 1998 Dec; 50(12):1078-86. PubMed ID: 9989352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.